The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products, which are often used to treat menopause, the Department of Health and Human Services announced on Monday.

During menopause, the ovaries stop making high levels of estrogen. HRT products are designed to replace the hormones that the body isn’t making enough of, according to the Cleveland Clinic . This can help reduce symptoms like hot flashes, vaginal dryness, insomnia and bone loss.

However, during the early 2000s, a Women’s Health Initiative study on HRT products found a “statistically non-significant increase in the risk of breast cancer diagnosis,” leading to the FDA applying black box warnings on HRT products, according to HHS’ announcement. Black box warnings are issu

See Full Page